BioAv Cancer Research Results
BioAv, bioavailability: Click to Expand ⟱
| Source: |
| Type: measurement |
Bioavailability (usually in %) absorbed by the body.
|
Liver, Liver Cancer: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
BioAv↑, *toxicity∅, eff↑,
| - |
in-vitro, |
Liver, |
SMMC-7721 cell |
|
|
|
- |
in-vitro, |
Nor, |
HL7702 |
|
|
|
*toxicity↓, radioP↑, BioAv↑, AntiTum↑, selectivity↑, eff↑, chemoP↑,
*BioAv↑, ROS↑, MMP↓, TumCP↓,
ROCK1↓, RAS↓, *BioAv↓, BioAv↑,
BioAv↑,
| - |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
BC, |
4T1 |
|
|
|
- |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
Liver, |
HepG2 |
|
|
|
eff↑, GSH↓, H2O2↑, ROS↑, *BioAv↑, selectivity↑, TumCCA↑, Apoptosis↑, Fenton↑, *toxicity?,
chemoP↑, selectivity↑, *BioAv↓, *BioAv↑, ROS↑, ROS↓, ROS↑,
GlucoseCon↓, lactateProd↓, ECAR↓, NO↓, ROS↑, HK2↓, PFK1↓, GAPDH↓, PKM2↓, LDHA↓, FASN↓, GLUT1↓, MCT1↓, MCT4↓, HCAR1↓, SDH↑, ChemoSen↑, ROS↑, BioAv↑, P53↑, NF-kB↓, pH↑,
| - |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
Liver, |
HepG2 |
|
|
|
- |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
Nor, |
HUVECs |
|
|
|
eff↑, Dose∅, *BioAv↑, selectivity↑, TumCP↓, Casp↑, PTEN↑, TSC1↑, mTOR⇅, Akt↓, PDK1↓, E6↓, E7↓, DNAdam↑, ROS↑, *BioAv↓, *BioEnh↑, *Half-Life∅,
Apoptosis↑, TumCCA↑, MMP↓, Bcl-2↓, BAX↑, cl‑Casp9↑, cl‑Casp3↑, Risk↓, *BioAv↑, *toxicity↑, TumCG↓, AntiTum↑, ROS↑, Cyt‑c↑, Fas↑, FasL↑, FADD↑,
Showing Research Papers: 1 to 10 of 10
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 10
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
Fenton↑, 1, GSH↓, 1, H2O2↑, 1, ROS↓, 1, ROS↑, 8,
Mitochondria & Bioenergetics ⓘ
MMP↓, 2, SDH↑, 1,
Core Metabolism/Glycolysis ⓘ
ECAR↓, 1, FASN↓, 1, GAPDH↓, 1, GlucoseCon↓, 1, HK2↓, 1, lactateProd↓, 1, LDHA↓, 1, MCT4↓, 1, PDK1↓, 1, PFK1↓, 1, PKM2↓, 1,
Cell Death ⓘ
Akt↓, 1, Apoptosis↑, 2, BAX↑, 1, Bcl-2↓, 1, Casp↑, 1, cl‑Casp3↑, 1, cl‑Casp9↑, 1, Cyt‑c↑, 1, FADD↑, 1, Fas↑, 1, FasL↑, 1, MCT1↓, 1,
DNA Damage & Repair ⓘ
DNAdam↑, 1, P53↑, 1,
Cell Cycle & Senescence ⓘ
TumCCA↑, 2,
Proliferation, Differentiation & Cell State ⓘ
mTOR⇅, 1, PTEN↑, 1, RAS↓, 1, TumCG↓, 1,
Migration ⓘ
ROCK1↓, 1, TSC1↑, 1, TumCP↓, 2,
Angiogenesis & Vasculature ⓘ
NO↓, 1,
Barriers & Transport ⓘ
GLUT1↓, 1,
Immune & Inflammatory Signaling ⓘ
HCAR1↓, 1, NF-kB↓, 1,
Cellular Microenvironment ⓘ
pH↑, 1,
Drug Metabolism & Resistance ⓘ
BioAv↑, 5, ChemoSen↑, 1, Dose∅, 1, eff↑, 4, selectivity↑, 4,
Clinical Biomarkers ⓘ
E6↓, 1, E7↓, 1,
Functional Outcomes ⓘ
AntiTum↑, 2, chemoP↑, 2, radioP↑, 1, Risk↓, 1,
Total Targets: 56
Pathway results for Effect on Normal Cells:
Drug Metabolism & Resistance ⓘ
BioAv↓, 3, BioAv↑, 5, BioEnh↑, 1, Half-Life∅, 1,
Functional Outcomes ⓘ
toxicity?, 1, toxicity↓, 1, toxicity↑, 1, toxicity∅, 1,
Total Targets: 8
Scientific Paper Hit Count for: BioAv, bioavailability
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:14 Cells:% prod#:% Target#:792 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page